Upgrade to SI Premium - Free Trial

Galera Therapeutics (GRTX)

0.15 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form SCHEDULE 13D Galera Therapeutics, Filed by: Hyare Parvinder Singh June 11, 2026 5:30 PM - SEC Filing Form 425 Galera Therapeutics, Filed by: Galera Therapeutics, Inc. June 2, 2026 4:32 PM - SEC Filing Form 425 Galera Therapeutics, Filed by: Galera Therapeutics, Inc. June 2, 2026 4:32 PM - SEC Filing Form SCHEDULE 13D/A Galera Therapeutics, Filed by: Emerald Bioventures, LLC May 29, 2026 4:58 PM - SEC Filing Form 4 Galera Therapeutics, For: May 15 Filed by: Opler Timothy May 29, 2026 4:57 PM - SEC Filing Form 425 Galera Therapeutics, Filed by: Galera Therapeutics, Inc. May 22, 2026 6:03 AM - SEC Filing Form 425 Galera Therapeutics, Filed by: Galera Therapeutics, Inc. May 21, 2026 5:21 PM - SEC Filing Galera Therapeutics converts remaining preferred stock to common shares May 19, 2026 4:04 PM - StreetInsider Form 8-K Galera Therapeutics, For: May 15 May 19, 2026 4:02 PM - SEC Filing Form 8-K Galera Therapeutics, For: May 11 May 15, 2026 6:36 AM - SEC Filing Form 10-Q Galera Therapeutics, For: Mar 31 May 14, 2026 7:16 AM - SEC Filing Form 8-K Galera Therapeutics, For: May 08 May 11, 2026 4:03 PM - SEC Filing Form 3 Galera Therapeutics, For: Apr 07 Filed by: Opler Timothy May 4, 2026 5:58 PM - SEC Filing Form SCHEDULE 13D Galera Therapeutics, Filed by: Emerald Bioventures, LLC April 27, 2026 4:17 PM - SEC Filing Form 425 Galera Therapeutics, Filed by: Galera Therapeutics, Inc. April 22, 2026 9:24 AM - SEC Filing Form 425 Galera Therapeutics, Filed by: Galera Therapeutics, Inc. April 22, 2026 9:19 AM - SEC Filing Form ARS Galera Therapeutics, For: Dec 31 April 20, 2026 5:01 PM - SEC Filing Form DEF 14A Galera Therapeutics, For: May 08 April 20, 2026 4:58 PM - SEC Filing Form 425 Galera Therapeutics, Filed by: Galera Therapeutics, Inc. April 15, 2026 6:16 AM - SEC Filing Form 425 Galera Therapeutics, Filed by: Galera Therapeutics, Inc. April 14, 2026 5:19 PM - SEC Filing Form 425 Galera Therapeutics, Filed by: Galera Therapeutics, Inc. April 14, 2026 5:15 PM - SEC Filing Form 425 Galera Therapeutics, Filed by: Galera Therapeutics, Inc. April 14, 2026 5:14 PM - SEC Filing Galera and Obsidian merge in $350 million all-stock deal April 14, 2026 2:08 PM - StreetInsider Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement April 14, 2026 2:08 PM - Globe NewsWire Form 425 Galera Therapeutics, Filed by: Galera Therapeutics, Inc. April 14, 2026 9:24 AM - SEC Filing Form 8-K Galera Therapeutics, For: Apr 14 April 14, 2026 9:18 AM - SEC Filing Obsidian Therapeutics and Galera Therapeutics announce merger with $350M funding April 14, 2026 8:54 AM - StreetInsider Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement April 14, 2026 8:54 AM - BizWire Form PRE 14A Galera Therapeutics, For: May 08 April 10, 2026 4:02 PM - SEC Filing Form SCHEDULE 13D Galera Therapeutics, Filed by: CHANG NANCY T April 10, 2026 12:30 PM - SEC Filing Form 4 Galera Therapeutics, For: Apr 07 Filed by: FRIEDMAN MICHAEL R. April 9, 2026 4:40 PM - SEC Filing Form 4 Galera Therapeutics, For: Apr 07 Filed by: CHANG NANCY T April 9, 2026 4:38 PM - SEC Filing Form 8-K Galera Therapeutics, For: Apr 07 April 9, 2026 4:01 PM - SEC Filing Form 8-K Galera Therapeutics, For: Apr 03 April 3, 2026 6:04 AM - SEC Filing Full Article List